Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Risk of Incident Venous Thromboembolism With Atopic Dermatitis and Treatment With Janus Kinase Inhibitors
Tai‐Li Chen, Ling-Ling Lee, Huei‐Kai Huang, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 11, pp. 1254-1254
Open Access | Times Cited: 43

Showing 26-50 of 43 citing articles:

JAK inhibitors and black box warnings: what is the future for JAK inhibitors?
Yekaterina Tokareva, Pankti Reid, Victor Yang, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 11, pp. 1385-1397
Open Access | Times Cited: 8
The Association Between Deep Vein Thrombosis, Pulmonary Embolism, and Janus Kinase Inhibitors: Reporting Status and Signal Detection in the Japanese Adverse Drug Event Report Database
Tae Maeshima, Sayaka Aisu, Naoki Ohkura, et al.
Drugs - Real World Outcomes (2024) Vol. 11, Iss. 3, pp. 369-375
Open Access | Times Cited: 2
The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases
Jasvinder A. Singh
BioDrugs (2023) Vol. 37, Iss. 5, pp. 625-635
Closed Access | Times Cited: 6
Risk of Incident Venous Thromboembolism Among Patients With Bullous Pemphigoid or Pemphigus Vulgaris: A Nationwide Cohort Study With Meta‐Analysis
Tai‐Li Chen, Wan‐Ting Huang, Ching‐Hui Loh, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 17
Open Access | Times Cited: 6
A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
Jonatan Ahrén, Mirnabi Pirouzifard, Björn Holmquist, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e072934-e072934
Open Access | Times Cited: 5
[Artículo traducido] Perfil de seguridad a largo plazo y usos fuera de indicación de los inhibidores de JAK en dermatología
L. Corbella‐Bagot, Constanza Riquelme‐Mc Loughlin, D. Morgado-Carrasco
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 9, pp. T784-T801
Open Access | Times Cited: 4
Controversies in Venous Thromboembolism Risk Assessment in Inflammatory Bowel Disease: A Narrative Review
Nikhil Sharma, Pavit Tewatia, Philip Harvey, et al.
Diagnostics (2024) Vol. 14, Iss. 19, pp. 2112-2112
Open Access | Times Cited: 1
JAK inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism
Yachar Dawudi, Samuel Benarroch, H. L. Helfer, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 9, Iss. 1, pp. 102667-102667
Open Access | Times Cited: 1
Emerging role of baricitinib in dermatology practice: All we need to know!
S. Dogra, Shikha Shah, Ayush Sharma, et al.
Indian Dermatology Online Journal (2023) Vol. 14, Iss. 2, pp. 153-153
Open Access | Times Cited: 3
Skin Anti-Inflammatory Potential with Reduced Side Effects of Novel Glucocorticoid Receptor Agonists
Enrica Flori, Sarah Mosca, Daniela Kovacs, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 267-267
Open Access | Times Cited: 2
Not just another klass (JAK) of inhibitors for allergies
Wesley H. Brooks, Yves Renaudineau
Deleted Journal (2024) Vol. 1, pp. 100001-100001
Open Access
Risk of incident venous thromboembolism in patients with atopic dermatitis: systematic analysis of the literature and meta-analysis
Yifei Wang, Zhiqiang Chen, Tingchao He, et al.
Journal of Thrombosis and Thrombolysis (2024)
Closed Access
Newer Treatments, Treatment Selection, Pipeline Therapies, and Personalized Medicine in Atopic Dermatitis: Where Are We Now?
J.Q. Del Rosso
Clinical Cases in Dermatology (2024), pp. 183-196
Closed Access
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy
J. Williams, Ryan Hum, Kira Rogers, et al.
Therapeutic Advances in Musculoskeletal Disease (2024) Vol. 16
Open Access
Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
Susan C. Villegas, Lorena Dima
American Journal of Therapeutics (2023) Vol. 30, Iss. 2, pp. e117-e125
Closed Access | Times Cited: 1
Safety of Oral Janus Kinase Inhibitors in the Treatment of Moderate-to-Severe Atopic Dermatitis
Shanthi Narla, Jonathan I. Silverberg
Dermatitis (2023) Vol. 34, Iss. 5, pp. 366-386
Closed Access | Times Cited: 1
JAMA Dermatology—The Year in Review, 2022
Kanade Shinkai
JAMA Dermatology (2023) Vol. 159, Iss. 5, pp. 473-473
Closed Access
A male perspective on alopecia areata: are we doing enough?
Leila Asfour, W Haddad, Laita Bokhari, et al.
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 10, pp. 1190-1191
Closed Access
Previous Page - Page 2

Scroll to top